Report Overview: The Global Antibody Drug Conjugates Market achieved a valuation of $4.75 Billion in 2022 and is anticipated to exceed $18.84 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 18.8% during the forecast period from 2024 to 2032. Key Market Players: Takeda Pharmaceutical Company Ltd. (Japan), F. Hoffmann-La Roche Ltd. (US), Pfizer Inc. (US),...